Physician profile
Marc E Snelson
NPI 1568575017
$10,865.86
in general payments reported to CMS, 2019-2025
36 companies · $794 in 2025
The $794 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,305 · 2020: $454 · 2021: $2,036 · 2022: $4,305 · 2023: $1,135 · 2024: $837 · 2025: $794.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,667 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,667.10 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $4,717.72 | 2021-2025 | Nexplanon, Jada System |
| Abbvie INC. | $903.93 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $629.32 | 2022-2025 | Veozah |
| Pfizer INC. | $530.92 | 2022-2025 | |
| Biotissue Holdings INC. | $527.65 | 2024-2025 | |
| Therapeuticsmd, INC. | $379.01 | 2019-2022 | |
| Lupin INC. | $311.00 | 2019-2021 | |
| Myovant Sciences INC. | $268.94 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $254.37 | 2019-2024 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $229.01 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $214.42 | 2023-2025 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $200.17 | 2019-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Omni Hysteroscope |
| Sage Therapeutics, LLC | $146.17 | 2022-2025 | Zurzuvae |
| Becton, Dickinson and Company | $142.59 | 2019 | |
| Arthrex, INC. | $130.88 | 2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $125.00 | 2019 | |
| Davol INC. | $121.61 | 2022 | |
| Mayne Pharma Commercial LLC | $117.14 | 2023-2025 | |
| Minerva Surgical, INC | $108.43 | 2019-2025 | |
| Agile Therapeutics, INC. | $106.52 | 2021-2022 | |
| Gynesonics, INC. | $104.24 | 2022 | |
| Intuitive Surgical, INC. | $101.08 | 2023 | |
| Exeltis, USA INC. | $77.47 | 2019-2024 | Slynd |
| Mylan Pharmaceuticals INC. | $60.86 | 2019-2021 | |
| Aspira Women'S Health INC | $52.84 | 2022 | |
| Evofem Biosciences, INC. | $49.00 | 2021-2022 | |
| Scynexis, INC. | $41.37 | 2022 | |
| Exact Sciences Corporation | $31.11 | 2023 | Cologuard Collection Kit |
| Dysis Medical, INC. | $28.89 | 2020-2021 | |
| Amgen INC. | $28.78 | 2019 | |
| Avion Pharmaceuticals | $28.25 | 2019-2022 | |
| Baxter Healthcare | $23.77 | 2020 | |
| Duchesnay USA Incorporated | $22.98 | 2019 | |
| Amag Pharmaceuticals, INC. | $20.83 | 2019 | |
| Ethicon US, LLC | $16.16 | 2020 | |
| Karl Storz Endoscopy-America | $13.43 | 2024 | Hopkins |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Snelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.